QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of oral...

 spero-therapeutics-q2-eps-003-beats-038-estimate-sales-14189m-up-from-10197m-yoy

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(...

 benzinga-bulls-and-bears-nvidia-palantir-marvell-technology--and-markets-rallied-in-may

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

 why-is-gsk-partner-spero-therapeutics-stock-skyrocketing-on-wednesday

GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral carbapen...

Core News & Articles
Market-Moving News for May 28th
05/28/2025 11:16:13

OKTA: -13% | Okta shares are trading lower following the company's Q1 earnings report. In its outlook, the company said it ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION